Literature DB >> 32746642

Catastrophic antiphospholipid antibody syndrome and multiple organ dysfunctions in critically ill patients with COVID-19.

Hisyovi Cárdenas Suri1, David Jimomila Bening1.   

Abstract

Entities:  

Keywords:  COVID-19; catastrophic antiphospholipid antibody syndrome; inflammation; multiple organ dysfunction; thrombosis

Mesh：

Year:  2020        PMID： 32746642     DOI： 10.1080/17476348.2020.1801427

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN： 1747-6348            Impact factor:   3.772


× No keyword cloud information.
  4 in total

Review 1.  An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination.

Authors:  Bulent Kantarcioglu; Omer Iqbal; Jeanine M Walenga; Bruce Lewis; Joseph Lewis; Charles A Carter; Meharvan Singh; Fabio Lievano; Alfonso Tafur; Eduardo Ramacciotti; Grigoris T Gerotziafas; Walter Jeske; Jawed Fareed
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

Review 2.  COVID-19: immunopathology, pathophysiological mechanisms, and treatment options.

Authors:  Larissa E van Eijk; Mathijs Binkhorst; Arno R Bourgonje; Annette K Offringa; Douwe J Mulder; Eelke M Bos; Nikola Kolundzic; Amaal E Abdulle; Peter Hj van der Voort; Marcel Gm Olde Rikkert; Johannes G van der Hoeven; Wilfred Fa den Dunnen; Jan-Luuk Hillebrands; Harry van Goor
Journal:  J Pathol       Date:  2021-03-25       Impact factor: 9.883

Review 3.  COVID-19, Antiphospholipid Antibodies, and Catastrophic Antiphospholipid Syndrome: A Possible Association?

Authors:  Georges El Hasbani; Ali T Taher; Ali Jawad; Imad Uthman
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2020-12-03

4.  Incidence and predictors of organ failure among COVID-19 hospitalized adult patients in Eastern Ethiopia. Hospital-based retrospective cohort study.

Authors:  Abdi Birhanu; Galana Mamo Ayana; Bedasa Taye Merga; Addisu Alemu; Belay Negash; Ahmed Seid; Yadeta Dessie
Journal:  BMC Infect Dis       Date:  2022-04-28       Impact factor: 3.667
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.